We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$3.56M
Cap. Flow
-$2.69M
Cap. Flow %
-2.11%
Top 10 Hldgs %
73.57%
Holding
78
New
20
Increased
12
Reduced
12
Closed
22

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$4.36M
2
CELC icon
Celcuity
CELC
+$3.08M
3
FCX icon
Freeport-McMoran
FCX
+$2.33M
4
AMZN icon
Amazon
AMZN
+$1.85M
5
AAOI icon
Applied Optoelectronics
AAOI
+$1.65M

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$2.68M
2
FIGR
Figure Technology Solutions
FIGR
+$2.35M
3
SPOT icon
Spotify
SPOT
+$2.32M
4
XOM icon
ExxonMobil
XOM
+$1.82M
5
NUVB icon
Nuvation Bio
NUVB
+$1.79M

Sector Composition

Rank Sector Weight
1 Healthcare 61.65%
2 Energy 24.24%
3 Consumer Discretionary 5.4%
4 Technology 4.57%
5 Materials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSPD icon
51
Lightspeed Commerce
LSPD
$1.31B
$112K 0.09%
12,500
– –
CMPS
52
Compass Pathways
CMPS
$1.53B
$85.7K 0.07%
+15,500
New +$104K
LTRX icon
53
Lantronix
LTRX
$240M
$78.6K 0.06%
+15,000
New +$91.7K
SSYS icon
54
Stratasys
SSYS
$679M
$78.1K 0.06%
10,000
– –
HIMS icon
55
Hims & Hers Health
HIMS
$6.43B
$51.9K 0.04%
+2,500
New +$59.1K
PDSB icon
56
PDS Biotechnology
PDSB
$38.4M
$18.1K 0.01%
30,000
– –
ALDX icon
57
Aldeyra Therapeutics
ALDX
$92.9M
– –
-41,000
Closed -$212K
APGE icon
58
Apogee Therapeutics
APGE
$10.1B
– –
-7,000
Closed -$528K
BHVN icon
59
Biohaven
BHVN
$2.03B
– –
-7,500
Closed -$84.7K
BW icon
60
Babcock & Wilcox
BW
$1.39B
– –
-36,500
Closed -$231K
DAWN
61
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-12,900
Closed -$120K
DVN icon
62
Devon Energy
DVN
$52.1B
– –
-22,000
Closed -$806K
EOG icon
63
EOG Resources
EOG
$79.2B
– –
-10,000
Closed -$1.05M
GPCR icon
64
Structure Therapeutics
GPCR
$3.41B
– –
-38,500
Closed -$2.68M
IBM icon
65
IBM
IBM
$211B
– –
-4,500
Closed -$1.33M
LQDA icon
66
Liquidia Corp
LQDA
$7.48B
– –
-8,500
Closed -$293K
MLTX icon
67
MoonLake Immunotherapeutics
MLTX
$1.57B
– –
-1,500
Closed -$19.8K
NVNO
68
enVVeno Medical
NVNO
$7.08M
– –
-3,286
Closed -$36.9K
SPOT icon
69
Spotify
SPOT
$103B
– –
-4,000
Closed -$2.32M
TEVA icon
70
Teva Pharmaceuticals
TEVA
$40.8B
– –
-23,000
Closed -$718K
TVTX icon
71
Travere Therapeutics
TVTX
$5.2B
– –
-3,000
Closed -$115K
WY icon
72
Weyerhaeuser
WY
$18B
– –
-4,500
Closed -$107K
YALA
73
Yalla Group
YALA
$818M
– –
-5,000
Closed -$34.7K
BTC
74
Grayscale Bitcoin Mini Trust ETF
BTC
$3.33B
– –
-1,800
Closed -$69.7K
SNDK
75
Sandisk
SNDK
$180B
– –
-3,500
Closed -$831K
1 2
3
4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, ACT Capital Management held 78 positions worth $127M, up 2.9% from $124M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

ACT Capital Management's Q1 2026 filing shows 20 new, 12 increased, 12 reduced and 22 closed positions. Its largest new stake was Alumis Inc: 174,250 shares worth $3.84M. The largest sale was Structure Therapeutics, an estimated $2.68M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Energy and Consumer Discretionary.

  • ACT Capital Management's largest Q1 2026 buy was Alumis Inc: 174,250 shares worth $3.84M.
  • ACT Capital Management added most to Celcuity in Q1 2026, an estimated $3.08M increase.
  • ACT Capital Management's biggest Q1 2026 reduction was ExxonMobil, cutting an estimated $1.82M.
  • ACT Capital Management fully exited Structure Therapeutics in Q1 2026, selling an estimated $2.68M.
  • ACT Capital Management's ten largest holdings make up 74% of its $127M portfolio in Q1 2026.
  • ACT Capital Management opened 20 new positions and closed 22 in Q1 2026.
  • ACT Capital Management's portfolio value rose 2.9% quarter-over-quarter to $127M.

Based on ACT Capital Management's 13F filing for Q1 2026, filed 8 May 2026.